Homepage
amfAR, The Foundation for AIDS Research, is dedicated to ending the global AIDS epidemic through innovative research.
Breakthroughs Amid Crisis
Focusing on HIV cure, mental health, prevention, and funding cuts, amfAR researchers set to participate in IAS 2025, the premier HIV science conference.
Researchers Target and Awaken Dormant HIV in Groundbreaking Advance
Researchers use lipid nanoparticles—LNP X—to insert mRNA capable of targeting and awakening dormant HIV, the main barrier to a cure.
FDA Approves Lenacapavir for HIV Pre-Exposure Prophylaxis
The FDA-approved lenacapavir for PrEP holds the potential to dramatically reduce HIV infections with its adherence-friendly twice-annual injection.
Explore more on Research, Policy and Advocacy, and TREAT Asia
New Edition of amfAR Magazine Out Now
This issue delves into artificial intelligence (AI) and its potential for revolutionizing HIV cure research, treatment, prevention, and care. Plus interviews with leading HIV researchers about the latest advances, as well as updates on our research, public policy, and TREAT Asia programs, benefit events, and much more.
Research Grants
amfAR, The Foundation for AIDS Research, is one of the world’s leading nonprofit organizations dedicated to the support of AIDS research, HIV prevention, treatment education, and advocacy. Since 1985, amfAR has raised nearly $950 million in support of its programs and has awarded more than 3,800 grants to research teams worldwide.
Research Grants Awarded
Target Grants: Request for Proposals
Donate to amfAR: Fuel Lifesaving Research
Make your contribution today and join the fight to #CureAIDS. Your support contributes to the advancement of amfAR’s cutting-edge HIV/AIDS research.
Show the world that a cure isn’t just possible—it’s within reach.
Leading the Way to a Cure
amfAR, The Foundation for AIDS Research, is one of the world’s leading nonprofit organizations dedicated to the support of AIDS research, HIV prevention, treatment education, and advocacy. Since 1985, amfAR has raised nearly $950 million in support of its programs and has awarded more than 3,800 grants to research teams worldwide.